← FDA Drug Approvals (Drugs@FDA)

AMLODIPINE BESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2026-01-22

Drug application

FDA Application #

ANDA219686

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMLODIPINE BESYLATE

Generic name

Amlodipine Besylate

Active ingredients

AMLODIPINE BESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS INC

First approval

2026-01-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown